| Literature DB >> 26429502 |
Qihui Liu1, Yuan Tian1, Xiangfeng Zhao2, Haifeng Jing1, Qi Xie1, Peng Li1, Dong Li1, Dongmei Yan1, Xun Zhu1.
Abstract
Macrophages are divided into two subpopulations: classically activated macrophages (M1) and alternatively activated macrophages (M2). BCG (Bacilli Calmette-GuC)rin) activates disabled naC/ve macrophages to M1 macrophages, which act as inflammatory, microbicidal and tumoricidal cells through cell-cell contact and/or the release of soluble factors. Various transcription factors and signaling pathways are involved in the regulation of macrophage activation and polarization. We discovered that BCG-activated macrophages (BAM) expressed a new molecule, and we named it Novel Macrophage Activated Associated Protein 1 (NMAAP1). The current study found that the overexpression of NMAAP1 in macrophages results in M1 polarization with increased expression levels of M1 genes, such as inducible nitric oxide synthase (iNOS), tumor necrosis factor alpha (TNF-N1), Interleukin 6 (IL-6), Interleukin 12 (IL-12), Monocyte chemoattractant protein-1 (MCP-1) and Interleukin-1 beta (IL-1N2), and decreased expression of some M2 genes, such as Kruppel-like factor 4 (KLF4) and suppressor of cytokine signaling 1 (SOCS1), but not other M2 genes, including arginase-1 (Arg-1), Interleukin (IL-10), transforming growth factor beta (TGF-N2) and found in inflammatory zone 1 (Fizz1). Moreover, NMAAP1 overexpression in the RAW264.7 cell line increased cytotoxicity against MCA207 tumor cells, which depends on increased inflammatory cytokines rather than cell-cell contact. NMAAP1 also substantially enhanced the phagocytic ability of macrophages, which implies that NMAAP1 promoted macrophage adhesive and clearance activities. Our results indicate that NMAAP1 is an essential molecule that modulates macrophages phenotype and plays an important role in macrophage tumoricidal functions.Entities:
Keywords: M1; NMAAP1; differentiation; macrophage; tumor
Mesh:
Substances:
Year: 2015 PMID: 26429502 PMCID: PMC4625070 DOI: 10.14348/molcells.2015.0125
Source DB: PubMed Journal: Mol Cells ISSN: 1016-8478 Impact factor: 5.034
Fig. 1.NMAAP1 expression was associated with the percent of M1 macrophages in BCG-activated peritoneal macrophages. (A) The percent of M1 macrophages in peritoneal macrophages on day 4, day 8 and day 12 were assessed using FACS. (B) Linear graphs analysis of the percent of M1 macrophages in BCG-activated macrophage. (C) IL-10 and NMAAP1 expression after BCG stimulation on day 4, day 8 and day 12 was determined using quantitative RT-PCR (qPCR). (D) Determination of IL-10 and TNF-α release using ELISA in BCG-stimulated mice sera after day 4, day 8 and day 12. Data are represented as mean ± S.E.M. from at least three independent experiments.
Fig. 2.pIRES2-EGFP/NMAAP1 transfection and transgene expression in RAW264.7 cells, Identification of stable transfectants expressing NMAAP1. (A) RAW264.7 cells were stably transfected with pIRES2-EGFP/NMAAP1 or pIRES2-EGFP/CONTROL. Bright field, DAPI, GFP and DAPI merged with GFP images were taken by a laser-scanning confocal microscope. (B, C) RT-PCR analysis. Expression in OV/RAW264.7 and ON/RAW264.7 cells were detected using RT-PCR. Bar graph displays means ± SEM of the percentage of NMAAP1/GAPDH ratio for the respective groups. (D, E) Protein expression of NMAAP1 in RAW264.7 cells normalized to β-Actin as an internal standard: lane 1, pIRES2-EGFP/CONTROL transfected cells; lane 2, pIRES2-EGFP/NMAAP1 transfected cells. Bar graph displays the densitometry results (arbitrary units [AU]) of the Western blots for the respective groups. Data are represented as mean±S.E.M. from at least three independent experiments. ***P < 0.001 (unpaired Student t test. compared with the corresponding control values).
Fig. 3.NMAAP1 altered the gene and protein expression of phenotype-related molecules. The highly expression of NMAAP1 regulated phenotype-specific markers for M1/M2 macrophages. (A, B) The percent of CD16/32 cells in ON/RAW264.7 cells using FACS. (C) M1/M2 genes were evaluated using quantitative real-time RT-PCR. (D, E) Release of M1/M2 cytokines was detected using ELISA in 6 h, 12 h, 24 h and 48 h culture supernatants of OV/RAW264.7 and ON/RAW264.7 cells. Data are represented as mean ± S.E.M. from at least three independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001 (unpaired Student t test. compared with the corresponding control values).
Fig. 4.Macrophage-mediated phagocytosis is modulated by NMAAP1. (A) The images show phagocytosis of fluorescent microspheres by OV/RAW264.7 and ON/RAW264.7 cells incubated with red carboxylate-modified fluorescent beads for 60 min. The cellular up-take of fluorescent beads was determined using fluorescence microscopy (× 40). (B) The phagocytosis rates and phagocytosis index of ON/RAW264.7 cells were obviously increased compared to the OV/RAW264.7 cells (**p < 0.01) (C, D) Relative phagocytosis was assayed using flow cytometry as the intensity of fluorescence. Data are represented as mean ± S.E.M. from at least three independent experiments. **P < 0.01 (unpaired Student t test. compared with the corresponding control values).
Fig. 5.Tumor cytotoxicity of OV/RAW264.7 and ON/RAW264.7 cells in vitro. (A) Tumor cytoxicity of supernatants of high NMAAP1-expressing RAW264.7 cells in vitro. The supernatant of ON/RAW264.7 cells exhibited significant cytotoxicity compared to the control group at 48 h and 72 h. (B) Contact cytotoxicity of paraformaldehyde-fixed macrophages. (C) Detection of cell apoptosis using immunofluorescence with Hoechst 33342 staining. (D) NMAAP1 plays an antioncogenic role in cytokines-induced MCA207 sarcoma cell apoptosis. MCA207 sarcomas cells cultured with supernatants of OV/RAW264.7 or ON/RAW264.7, and apoptosis was evaluated using 7AAD/Annexin-V dual staining at 24 h. Cells in the upper right (UR) portion are late-stage apoptotic cells, upper left (UL) are necrotic cells, and cells in the lower left (LL) and lower right (LR) portions are viable and early apoptotic cells, respectively. (E) Bar graph showing the percentage of apoptotic MCA207 cells using flow cytometry. Data are represented as mean ± S.E.M. from at least three independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001 (unpaired Student t test. compared with the corresponding control values).
| NMAAP1: | Forward 5′-CCTTCCCCTGCCCAATA-3′ |
| Reverse 5′-TCCACGAAACCTTCCACA-3′ | |
| iNOSII: | Forward 5′-ATGGCAACATCAGGTCGG-3′ |
| Reverse 5′-GCACAACTGGGTGAACTCC-3′ | |
| IL12p40: | Forward 5′-ACTCACATCTGCTGCTCCAC-3′ |
| Reverse 5′- CGTCCGGAGTAATTTGGTGC-3′ | |
| IL-6: | Forward 5′-TAGTCCTTCCTACCCCAATTT-3′ |
| Reverse 5′-TTGGTCCTTAGCCACTCCTTC-3′ | |
| KLF4: | Forward 5′-TATACATTCCGCCACAGCAG-3′ |
| Reverse 5′-CGCCTCTTGCTTAATCTTGG-3′ | |
| MCP-1: | Forward 5′-TTAAAAACCTGGATCGGAACC-3′ |
| Reverse 5′-GCATTAGCTTCAGATTTACGG-3′ | |
| Fizz1: | Forward 5′-CCCTTCTCATCTGCATCT-3′ |
| Reverse 5′-CTGGATTGGCAAGAAGTTCC-3′ | |
| SOCS1: | Forward 5′-CTGCGGCTTCTATTGGGGAC-3′ |
| Reverse 5′-AAAAGGCAGTCGAAGTCTCG-3′ | |
| SOCS3: | Forward 5′-CCCTTGCAGTTCTAAGTTCAA-3′ |
| Reverse 5′-ACCTTTGACAAGCGGACTCTC-3′ | |
| ARG-1: | Forward 5′-CAGTCTGGCAGTTGGAAGC-3′ |
| Reverse 5′-GGTTGTCAGGGGAGTGTTG-3′ | |
| TNF-α: | Forward 5′-ACTGAACTTCGGGGTGATCG-3′ |
| Reverse 5′-CCACTTGGTGGTTTGCTACG-3′ | |
| IL-10: | Forward 5′-GTTGCCAAGCCTTATCGG-3′ |
| Reverse 5′-GCTCTTATTTTCACAGGGGAG-3′ | |
| TGF-β: | Forward 5′-GAGGCGGTGCTCGCTTTGTA-3′ |
| Reverse 5′-CGTTGTTGCGGTCCACCATTA-3′ | |
| GAPDH: | Forward 5′-GACTTCAACAGCAACTCCCACTC-3′ |
| Reverse 5′-TAGCCGTATTCATTGTCATACCAG-3′ |